Midtvedt K, Hartmann A, Midtvedt T, Brekke I B
Nephrol Dial Transplant. 1998 Jul;13(7):1637-41. doi: 10.1093/ndt/13.7.1637.
Perioperative antibiotic prophylaxis may prevent infection following renal transplantation but it also contributes to development of resistant microorganisms. With refined surgical techniques, improved graft preservation, and immunosuppressive monitoring during recent decades one can question the present use of perioperative antibiotic prophylaxis. We retrospectively evaluated the incidence of infection in our renal transplant centre where antibiotic prophylaxis is not routinely used in renal recipients. Concurrently we performed a survey of perioperative antibiotic use to establish the current world-wide practice.
Infection episodes were evaluated from records of 448 adult renal transplant recipients (January 1994 to August 1996) at our centre. A questionnaire was mailed to 103 centres addressing the number of kidney transplantations in 1995, donor source (living vs cadaveric) and details on use of perioperative antibiotic prophylaxis.
Single-centre study. Renal transplantation was performed without antibiotic prophylaxis in 377 patients (84%). Thirteen patients (3.4%) had early postoperative infections, nine with urinary-tract infection tended to have urinary catheter for a longer period than those without infection (5.0 +/- 2.7 vs 3.4 +/- 1.4 days, P = 0.27) and cadaveric kidney recipients to have higher incidence of infections (4.5 vs 1.5% P = 0.14). All infection episodes were successfully treated. The infection incidence in 71 (16%) 'high-risk' patients selected for antibiotic treatment was 4.2%. World-wide survey. Data were obtained from 101 centres in five continents representing 10532 renal transplants. Ninety centres (89%) used perioperative antibiotic prophylaxis.
The infection incidence in patients who did not receive perioperative antibiotic prophylaxis was the same as in a small group of selected patients who received prophylaxis. The incidence was lower than usually reported in the literature. In contrast perioperative antibiotic prophylaxis is given to all patients in almost 90% of transplant centres worldwide. A reduction of prophylactic antibiotic use is encouraged.
围手术期抗生素预防可预防肾移植术后感染,但也会促使耐药微生物的产生。近几十年来,随着手术技术的改进、移植物保存的改善以及免疫抑制监测的发展,人们对目前围手术期抗生素预防的使用提出了质疑。我们回顾性评估了我们肾移植中心的感染发生率,该中心在肾移植受者中不常规使用抗生素预防。同时,我们对围手术期抗生素的使用情况进行了一项调查,以确定当前全球范围内的做法。
从我们中心448例成年肾移植受者(1994年1月至1996年8月)的记录中评估感染事件。向103个中心邮寄了一份问卷,内容涉及1995年肾移植的数量、供体来源(活体与尸体)以及围手术期抗生素预防使用的详细情况。
单中心研究。377例患者(84%)在未使用抗生素预防的情况下进行了肾移植。13例患者(3.4%)术后早期发生感染,9例发生尿路感染的患者留置导尿管的时间往往比未感染患者更长(5.0±2.7天对3.4±1.4天,P=0.27),尸体肾受者的感染发生率更高(4.5%对1.5%,P=0.14)。所有感染事件均得到成功治疗。71例(16%)被选择接受抗生素治疗的“高危”患者的感染发生率为4.2%。全球调查。数据来自五大洲的101个中心,代表10532例肾移植。90个中心(89%)使用围手术期抗生素预防。
未接受围手术期抗生素预防的患者的感染发生率与一小部分接受预防的选定患者相同。该发生率低于文献中通常报道的发生率。相比之下,全球近90%的移植中心对所有患者都给予围手术期抗生素预防。鼓励减少预防性抗生素的使用。